Impact of Gastro-Hepatic Pack on Liver Functions in Patients with Type 2 Diabetes Mellitus—A Pilot Study

Background: Diabetes mellitus is a metabolic disease caused by an insufficient amount of insulin that is marked by persistently high blood sugar levels and is also associated with impaired liver function and liver abnormalities. The gastro-hepatic pack (GHP) is a hydrotherapeutic therapy used to treat a variety of diseases, including diabetes mellitus. Nevertheless, no study has reported the effect of GHP on liver function in people with type 2 diabetes mellitus (T2DM). Thus, the goal of this study was to evaluate the effect of GHP on liver functioning of participants with T2DM.